par Ades Moraes, Felipe ;Zardavas, Dimitros ;Da Costa Pereira Pinto, Ana Catarina ;Aftimos, Philippe ;de Azambuja, Evandro ;Criscitiello, Carmen
Référence Breast, 23, 4, page (317-328)
Publication Publié, 2014
Référence Breast, 23, 4, page (317-328)
Publication Publié, 2014
Article révisé par les pairs
Titre: |
|
Auteur: | Ades Moraes, Felipe; Zardavas, Dimitros; Da Costa Pereira Pinto, Ana Catarina; Aftimos, Philippe; de Azambuja, Evandro; Criscitiello, Carmen |
Informations sur la publication: | Breast, 23, 4, page (317-328) |
Statut de publication: | Publié, 2014 |
Sujet CREF: | Chirurgie |
Mots-clés: | Anti-HER2 agents |
Biomarkers | |
Breast cancer | |
Cardiotoxicity | |
Chemotherapy | |
Endocrine therapy | |
MeSH keywords: | Angiogenesis Inhibitors -- adverse effects |
Anthracyclines -- adverse effects | |
Antibodies, Monoclonal, Humanized -- adverse effects | |
Antineoplastic Agents -- adverse effects | |
Antineoplastic Agents, Alkylating -- adverse effects | |
Antineoplastic Agents, Hormonal -- adverse effects | |
Breast Neoplasms -- drug therapy | |
Cardiotoxicity | |
Female | |
Heart Diseases -- chemically induced | |
Heart Failure -- chemically induced | |
Humans | |
Myocardial Ischemia -- chemically induced | |
Note générale: | SCOPUS: re.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0960-9776 |
info:doi/10.1016/j.breast.2014.04.002 | |
info:pii/S0960977614000708 | |
info:scp/84902550680 | |
info:pmid/24794210 |